BELL BIOSYSTEMS, INC.

Profile

Company Names

BELL BIOSYSTEMS, INC.

Addresses

953 INDIANA STREET, SAN FRANCISCO, CA 94107

MOLECULAR MEDICINE RESEARCH INSTITUTE, 525 DEL REY AVENUE, SUITE B, SUNNYVALE, CA 94085

Phone Numbers

(703) 343-6477
408-523-6260

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$4,180,250.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-12-23 
$3,810,250.00 
$3,810,250.00 
$0.00 
Equity 
2
2012-05-17 
$250,000.00 
$2,000,000.00 
$1,750,000.00 
Equity, Debt 
1
2011-06-11 
$120,000.00 
$120,000.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CALEB 
B. 
BELL 
EXECUTIVE OFFICER, DIRECTOR
BELL BIOSYSTEMS, INC.
DANIEL 
 
BELL 
EXECUTIVE OFFICER, DIRECTOR
BELL BIOSYSTEMS, INC.   |  ACUITY POLYMERS, INC.
STUART 
 
BERMAN 
DIRECTOR
BELL BIOSYSTEMS, INC.   |  ZALICO VARIABLE SERIES II SEPARATE ACCOUNT   |  ZURICH AMERICAN LIFE INSURANCE CO   |  ZALICO VARIABLE SERIES VI SEPARATE ACCOUNT   |  ZALICO VARIABLE SERIES I SEPARATE ACCOUNT   |  ZALICO VARIABLE ANNUITY SEPARATE ACCOUNT -- 2   |  ZALICO-S VL SERIES ACCOUNT - 2   |  HNW PPVUL SERIES ACCOUNT - 1   |  ZALICO VARIABLE SERIES III SEPARATE ACCOUNT   |  HNW PPVA SERIES ACCOUNT - 1   |  VL SERIES ACCOUNT-1
BELL 
B. 
CALEB 
EXECUTIVE OFFICER, DIRECTOR
BELL BIOSYSTEMS, INC.
BELL, III 
B. 
CALEB 
EXECUTIVE OFFICER, DIRECTOR
BELL BIOSYSTEMS, INC.
CHRISTIAN 
 
OLGAARD 
DIRECTOR
BELL BIOSYSTEMS, INC.
UNA 
 
RYAN 
DIRECTOR
IQUUM INC   |  BELL BIOSYSTEMS, INC.   |  BIOARRAY THERAPEUTICS, INC.   |  NATIVIS, INC.   |  ELEMENTAL MACHINES, INC.   |  QUINCE THERAPEUTICS, INC.
GIL 
 
VAN BOKKELEN 
DIRECTOR
ATHERSYS, INC / NEW   |  BELL BIOSYSTEMS, INC.   |  FLOW PHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-04-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-23 
2014-01-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-23 
2012-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-06-11 
2012-05-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-05-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#